Nanotechnology Now - Press Release: Eugene Science Concluded the Supply Contract of CholZero(TM) Capsule to the North American Region With CERAGEM International, Inc., a Global Medical D

Home > Press > Eugene Science Concluded the Supply Contract of CholZero(TM) Capsule to the North American Region With CERAGEM International, Inc., a Global Medical D

Abstract:
Eugene Science, Inc. (OTCBB: EUSI), a developer and marketer of nutraceutical products, announced that it concluded the exclusive contract for sales and supply of CholZero™ Capsule to North America, with CERAGEM International, Inc., which is a global medical device & health company.

Eugene Science Concluded the Supply Contract of CholZero(TM) Capsule to the North American Region With CERAGEM International, Inc., a Global Medical D

LOS ANGELES, CA | Posted on March 22nd, 2007

Through this contract, Eugene Science Inc. changed the sales and supply source from Nutra NanoTech., which had been in charge of distribution to North America including the U.S., in the meantime, to CERAGEM International, Inc., which already contained the satisfying and strong sales network over the world. It is expected that North American marketing for a product, CholZero™, which targets the Cholesterol market of 15 to 18 percent scale, among the U.S. functional food markets of 80 billion dollar scale, will be activated.

Recently, Plant Sterol (CZ™) of Eugene Science Inc. succeeded to be recognized as a health function food raw material by Korea Food & Drug Administration (KFDA), and in June 2005, Eugene Science Inc. concluded the contract for dwelling in the Jang-An business complex and for investment, with Gyeonggi-Do and Telos Investment Company(U.S.), and at present, it is progressing the construction for establishment of manufacturing facilities related to Bio Technologies and Cholesterol raw materials. Also, Archer Daniels Midland Company, which concluded the raw materials exclusive contract for the North American and European region, is actively progressing marketing under the CardioAid-CZ™ brand, which utilized Eugene Science's CZ™, a raw material for lowering the absorption of cholesterol.

Along with these successful marketing activities and business environmental improvement in Korea and abroad, due to this contract, Eugene Science Inc. started full-scale sales of the complete product of CholZero™ not only to the U.S., but also to Canada. It is prospected that the position of Eugene Science will become stronger. In particular, CERAGEM International, Inc. is expected to expand that sale not only to the North America, but also, within the near time, to China, which is huge consumption market.

####

About CERAGEM International, Inc.
CERAGEM International, Inc. ( http://www.ceragem.com ), which is a global healthcare products marketing company, has corporations or sole distributors in around 50 countries over the world including the USA, China, Germany, Chile, Turkey, Russia, and the Middle East, and also is a total health care supply company that sells global medical devices, whose sales amount in 2005 was 165 million dollars.

In particular, the combination between CholZero™, with which the scientific efficiency of Eugene Science was proved, and the unique, experienced sales marketing of CERAGEM International, Inc., whose products are very reliable to consumers, is expected to make a synergy effect that enables CholZero™ to be infiltrated into and expanded in, the Northern American market.

For more information, please click here

Contacts:
Mirador Consulting, Inc.
Frank Benedetto
Phone 561-989-3600

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: